Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Variants Associated with Susceptibility to Pancreatic Cancer and Melanoma Do Not Reciprocally Affect Risk

Lang Wu, Alisa M. Goldstein, Kai Yu, Xiaohong Rose Yang, Kari G. Rabe, Alan A. Arslan, Federico Canzian, Brian M. Wolpin, Rachael Stolzenberg-Solomon, Laufey T. Amundadottir and Gloria M. Petersen
Lang Wu
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisa M. Goldstein
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Yu
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohong Rose Yang
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari G. Rabe
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan A. Arslan
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Canzian
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian M. Wolpin
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachael Stolzenberg-Solomon
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laufey T. Amundadottir
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gloria M. Petersen
1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0627 Published June 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2014 to April 2021

AbstractFull-text HTMLPDF
Total14551397808

Cited By

Article Information

Volume 23, Issue 6, pp. 1121-1124

DOI 
https://doi.org/10.1158/1055-9965.EPI-13-0627
PubMed 
24642353

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Received January 22, 2014
  • Accepted February 18, 2014
  • Published first March 18, 2014.

Article Versions

  • Previous version (March 18, 2014 - 06:11).
  • Previous version (May 9, 2014 - 07:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2014 American Association for Cancer Research.

Author Information

  1. Lang Wu1,
  2. Alisa M. Goldstein2,
  3. Kai Yu2,
  4. Xiaohong Rose Yang2,
  5. Kari G. Rabe1,
  6. Alan A. Arslan3,
  7. Federico Canzian5,
  8. Brian M. Wolpin4,
  9. Rachael Stolzenberg-Solomon2,
  10. Laufey T. Amundadottir2, and
  11. Gloria M. Petersen1
  1. Authors' Affiliations: 1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Departments of Obstetrics and Gynecology and Environmental Medicine, New York University School of Medicine, New York, New York; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  1. Corresponding Author:
    Gloria M. Petersen, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905. Phone: 507-538-1563; Fax: 507-266-2478; E-mail: Petersen.Gloria{at}mayo.edu
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (6)
June 2014
Volume 23, Issue 6
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Variants Associated with Susceptibility to Pancreatic Cancer and Melanoma Do Not Reciprocally Affect Risk
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Variants Associated with Susceptibility to Pancreatic Cancer and Melanoma Do Not Reciprocally Affect Risk
Lang Wu, Alisa M. Goldstein, Kai Yu, Xiaohong Rose Yang, Kari G. Rabe, Alan A. Arslan, Federico Canzian, Brian M. Wolpin, Rachael Stolzenberg-Solomon, Laufey T. Amundadottir and Gloria M. Petersen
Cancer Epidemiol Biomarkers Prev June 1 2014 (23) (6) 1121-1124; DOI: 10.1158/1055-9965.EPI-13-0627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variants Associated with Susceptibility to Pancreatic Cancer and Melanoma Do Not Reciprocally Affect Risk
Lang Wu, Alisa M. Goldstein, Kai Yu, Xiaohong Rose Yang, Kari G. Rabe, Alan A. Arslan, Federico Canzian, Brian M. Wolpin, Rachael Stolzenberg-Solomon, Laufey T. Amundadottir and Gloria M. Petersen
Cancer Epidemiol Biomarkers Prev June 1 2014 (23) (6) 1121-1124; DOI: 10.1158/1055-9965.EPI-13-0627
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Soft drink and juice consumption and renal cell carcinoma
  • Associations of ACEi and ARB with CRC Risk
  • Fusobacterium nucleatum antibody and CRC risk
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement